Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Flexpharm
New Brighton, Minnesota, United Statesflexpharmausa.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Flex Pharma, LLC is a clinical-stage specialty pharmaceutical company focused on transforming the formulation and delivery of complex oncology therapeutics. Utilizing its proprietary ElectroNanoSpray (ENS) platform technology—a non-thermal spray drying process that uses electric-field forces—the company reformulates established oncology molecules to enhance bioavailability, eliminate food effects, and overcome pH-dependent solubility challenges. Flex Pharma's innovative approach is validated by the FDA approvals of Phyrago (dasatinib) and Cavhanza (nilotinib Orally Disintegrating Tablets), the latter developed in partnership with Cycle Pharmaceuticals to allow flexible dosing with acid-reducing agents. The company is also advancing a robust pipeline of early-stage oncology assets to address significant unmet medical needs within the oncology landscape.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Cycle PharmaceuticalsHanda Therapeutics
Beyond the preview
Go deeper on Flexpharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Flexpharm.